Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Melamed

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
Archives of Pathology & Laboratory Medicine|July 3, 2018
Prostate Cancers Detected by Magnetic Resonance Imaging-Targeted Biopsies Have a Higher Percentage of Gleason Pattern 4 Component and Are Less Likely to Be Upgraded in Radical ProstatectomiesYani Zhao, Fang-Ming Deng, Hongying Huang, et al.
The Prostate|April 3, 2014
Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironmentQiuyang Zhang, Sen Liu, Qingsong Zhang, et al.
The Journal of Experimental Medicine|December 16, 2025
Antibiotic use in early life impairs MAIT cell-mediated immunity in adulthoodGabrielle R LeBlanc, Adam L Sobel, Jonathan Melamed, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 24, 2011
Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localizationAndrew B Rosenkrantz, Lorenzo Mannelli, Xiangtian Kong, et al.
Cancer Immunity|May 16, 2003
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancerHuiming Zhang, Jonathan Melamed, Ping Wei, et al.
The American Journal of Surgical Pathology|June 11, 2021
Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted BiopsiesFang-Ming Deng, Bogdan Isaila, Derek Jones, et al.
BMC Bioinformatics|March 26, 2004
The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue ResourceJules J Berman, Milton Datta, Andre Kajdacsy-Balla, et al.
European Urology|November 23, 2013
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trialJames S Wysock, Andrew B Rosenkrantz, William C Huang, et al.
American Journal of Clinical and Experimental Urology|August 16, 2014
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinomaWeisheng Xu, Liying Yang, Peng Lee, et al.
European Urology|November 4, 2015
Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical ProstatectomyFang-Ming Deng, Nicholas M Donin, Ruth Pe Benito, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
Archives of Pathology & Laboratory Medicine|July 3, 2018
Prostate Cancers Detected by Magnetic Resonance Imaging-Targeted Biopsies Have a Higher Percentage of Gleason Pattern 4 Component and Are Less Likely to Be Upgraded in Radical ProstatectomiesYani Zhao, Fang-Ming Deng, Hongying Huang, et al.
The Prostate|April 3, 2014
Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironmentQiuyang Zhang, Sen Liu, Qingsong Zhang, et al.
The Journal of Experimental Medicine|December 16, 2025
Antibiotic use in early life impairs MAIT cell-mediated immunity in adulthoodGabrielle R LeBlanc, Adam L Sobel, Jonathan Melamed, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 24, 2011
Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localizationAndrew B Rosenkrantz, Lorenzo Mannelli, Xiangtian Kong, et al.
Cancer Immunity|May 16, 2003
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancerHuiming Zhang, Jonathan Melamed, Ping Wei, et al.
The American Journal of Surgical Pathology|June 11, 2021
Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted BiopsiesFang-Ming Deng, Bogdan Isaila, Derek Jones, et al.
BMC Bioinformatics|March 26, 2004
The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue ResourceJules J Berman, Milton Datta, Andre Kajdacsy-Balla, et al.
European Urology|November 23, 2013
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trialJames S Wysock, Andrew B Rosenkrantz, William C Huang, et al.
American Journal of Clinical and Experimental Urology|August 16, 2014
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinomaWeisheng Xu, Liying Yang, Peng Lee, et al.
European Urology|November 4, 2015
Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical ProstatectomyFang-Ming Deng, Nicholas M Donin, Ruth Pe Benito, et al.
Pageof 21